Literature DB >> 26085611

Evaluation of the Efficiency of the Sample Inactivation Reagent in the Abbott RealTime MTB Assay for Inactivation of Mycobacterium tuberculosis.

Chao Qi1, Carole Wallis2, Vihanga Pahalawatta3, Andrea Frank3, Neeshan Ramdin2, Raquel Viana2, Klara Abravaya3, Gregor Leckie3, Ning Tang3.   

Abstract

The Abbott RealTime MTB assay is a nucleic acid amplification test (NAAT) for the detection of Mycobacterium tuberculosis complex DNA. The sample inactivation procedure used in the assay, consisting of one part sample treated with 3 parts inactivation reagent for 60 min, effectively reduced viscosity and inactivated M. tuberculosis in clinical specimens.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Year:  2015        PMID： 26085611      PMCID： PMC4540903          DOI： 10.1128/JCM.00598-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  3 in total

1.  Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings.

Authors:  Padmapriya P Banada; Satheesh K Sivasubramani; Robert Blakemore; Catharina Boehme; Mark D Perkins; Kevin Fennelly; David Alland
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

2.  Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study.

Authors:  E Tortoli; P Cichero; C Piersimoni; M T Simonetti; G Gesu; D Nista
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

3.  Drug tolerance in Mycobacterium tuberculosis.

Authors:  R S Wallis; S Patil; S H Cheon; K Edmonds; M Phillips; M D Perkins; M Joloba; A Namale; J L Johnson; L Teixeira; R Dietze; S Siddiqi; R D Mugerwa; K Eisenach; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191
  3 in total
  3 in total

1.  Performance of the Abbott RealTime MTB and MTB RIF/INH Assays in a Setting of High Tuberculosis and HIV Coinfection in South Africa.

Authors:  Lesley Scott; Anura David; Lara Noble; Matilda Nduna; Pedro Da Silva; Andrew Black; Francois Venter; Wendy Stevens
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

2.  Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh.

Authors:  Joshua Kostera; Gregor Leckie; Klara Abravaya; Hong Wang
Journal:  Infect Drug Resist       Date:  2018-05-11       Impact factor: 4.003

3.  Closed-type pre-treatment device for point-of-care testing of sputum.

Authors:  Hyun-Ju Park; Ayoung Woo; Jae Min Cha; Kyu-Sung Lee; Min-Young Lee
Journal:  Sci Rep       Date:  2018-11-07       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.